TY - JOUR ID - 170299 TI - Review Current and Emerging Treatment Options for Alzheimer's Disease JO - Neurology Letters JA - NL LA - en SN - AU - Kumar Vats, Dimple AU - Biswas, Nistara AU - Pandian, Preethi AU - Kamalakannan, Anupam AD - Department of Neurology, Poona Hospital and Research Centre, Pune, Maharashtra, Vertigo and Deafness Clinic, Institute of Neurotology, Kolkata, West Bengal, India AD - Department of Neurology, Christian Medical College and Hospital, Ludhiana, Punjab, India Y1 - 2023 PY - 2023 VL - 2 IS - 1 SP - 1 EP - 5 KW - Alzheimer's disease KW - treatment KW - dementia KW - therapy DO - 10.52547/nl.2.1.1 N2 - Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects cognitive function, memory, and behavior. Currently, available treatments for AD primarily focus on managing symptoms, rather than addressing the underlying disease process. However, there is ongoing research and development in the field of AD treatment, with the hope of finding new and more effective therapies. Medications, such as cholinesterase inhibitors and NMDA receptor antagonists, are primarily used to treat cognitive symptoms of the disease. Non-pharmacological interventions, such as cognitive and memory training, occupational therapy, social and recreational activities, and environmental modifications, can also play a significant role in managing the symptoms of AD. Emerging treatments for AD include drugs that target beta-amyloid and tau protein, stem cell-based therapies, non-invasive brain stimulation techniques, and dietary and lifestyle interventions. The results of ongoing clinical trials will provide important information on the safety and efficacy of these treatments and will help to guide future research. It is important to note that while there are promising developments in the field, more research is needed to fully understand the underlying causes of AD and to develop effective treatments. This paper provides an overview of current and emerging treatments for AD. It discusses the role of medications, non-pharmacological interventions, and emerging treatments in managing the symptoms of AD. It also provides an update on the latest emerging treatments for AD, including drugs that target beta-amyloid and tau protein, stem cell-based therapies, non-invasive brain stimulation techniques, and dietary and lifestyle interventions. The paper concludes by emphasizing the need for further research and development in the field of AD treatment. UR - https://www.neurologyletters.com/article_170299.html L1 - https://www.neurologyletters.com/article_170299_0197e5e9e7da2a45a7e112b4cacfd349.pdf ER -